Trials / Completed
CompletedNCT01331733
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist Following Two Protocols of Ovulation Induction for Intrauterine Insemination
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 131 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 36 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effectiveness of protocols of ovarian hyperstimulation combining urinary gonadotrophins + GnRH antagonist vs urinary gonadotrophins, to achieve clinical pregnancy in females undergoing intrauterine insemination. Study hypothesis: protocols combining urinary gonadotrophins + GnRH antagonist should be more effective than monotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hMG-HP | |
| DRUG | hMG + GnRH antagonist |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-10-01
- Completion
- 2009-03-01
- First posted
- 2011-04-08
- Last updated
- 2011-04-08
Locations
7 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01331733. Inclusion in this directory is not an endorsement.